Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA007522-05
Application #
2120026
Study Section
Special Emphasis Panel (SRCD (17))
Project Start
1991-12-15
Project End
1997-11-30
Budget Start
1995-12-01
Budget End
1997-11-30
Support Year
5
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Physiology
Type
Schools of Medicine
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Letchworth, S R; Daunais, J B; Hedgecock, A A et al. (1997) Effects of chronic cocaine administration on dopamine transporter mRNA and protein in the rat. Brain Res 750:214-22
Martin, T J; Miller Jr, M; Dworkin, S I et al. (1997) Alteration of local cerebral glucose utilization following intravenous administration of heroin in Fischer 344 rats. Brain Res 755:313-8
Daunais, J B; Hart, S L; Hedgecock-Rowe, A et al. (1997) Alterations in behavior and opioid gene expression induced by the novel tropane analog WF-31. Brain Res Mol Brain Res 50:293-304
Porrino, L J; Miller, M; Hedgecock, A A et al. (1997) Local cerebral metabolic effects of the novel cocaine analog, WF-31: comparisons to fluoxetine. Synapse 27:26-35
Lyons, D; Porrino, L J (1997) Dopamine depletion in the rostral nucleus accumbens alters the cerebral metabolic response to cocaine in the rat. Brain Res 753:69-79
Porrino, L J; Davies, H M; Childers, S R (1995) Behavioral and local cerebral metabolic effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-tolyl)-tropane. J Pharmacol Exp Ther 272:901-10
Porrino, L J; Migliarese, K; Davies, H M et al. (1994) Behavioral effects of the novel tropane analog, 2 beta-propanoyl-3 beta-(4-toluyl)-tropane (PTT). Life Sci 54:PL511-7
Porrino, L J; Williams-Hemby, L; Davies, H M (1994) Metabolic mapping methods for the identification of the neural substrates of the effects of novel tropane analogs. NIDA Res Monogr 138:71-86
Porrino, L J (1993) Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology (Berl) 112:343-51